Defendants In Securities Class Action Against Drug Maker Seek Dismissal

(November 9, 2017, 3:15 PM EST) -- NEW YORK — Dismissal of a second amended shareholder class action lawsuit against a drug maker and certain of its current and former executive officers is warranted because the lead plaintiff...
To view the full article, register now.